Continuous Saphenous Block Versus Continuous Femoral Block for Total Knee Arthroplasty

Continuous Saphenous Block Vs. Continuous Femoral Block for Total Knee Arthroplasty: Prospective, Randomized, Double Blind Study.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01250041

Enrollment

Registered

2010-11-30

Start date

2011-01-31

Completion date

2011-12-31

Last updated

2010-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty Secondary to Osteoarthritis

Brief summary

Strength of the Quadriceps Muscle is key to recover from Total Knee Arthroplasty. In this study we compare two techniques for pain control after total knee arthroplasty in terms of preserving the motor function (the strength of the quadriceps muscles of the thigh) which will facilitate the rehabilitation and accelerate the hospital discharge. We will use ultrasound guided technique to block either the femoral nerve in the control group or the saphenous nerve in the experimental group. The primary outcome is the functional capacity and the impact of each block on the ability to walk by measuring the distance patients are able to walk in two minutes in post operative day one in the two groups. The secondary outcome is the morphine consumption in the two groups.

Interventions

PROCEDUREcontinuous femoral nerve block

ultrasound guided femoral nerve catheter insertion.

PROCEDUREcontinuous saphenous nerve block

ultrasound guided saphenous nerve catheter insertion

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- Subject age over 18 years coming for total knee arthroplasty secondary to osteoarthritis

Exclusion criteria

* ASA 4-5 * Abnormal liver enzymes, hepatic failure, renal failure and cardiac failure if they become contraindication for the use of regional anesthesia * Contraindications for spinal anesthesia * Morbid obesity * Organ transplant * Neuropathic pain * History of stroke or major neurological deficit * Sensory and motor disorders in the operated limb * Previous drug dependency * Chronic use of opioids * Allergy to local anesthetics * Inability to comprehend pain assessment

Design outcomes

Primary

Measure	Time frame
to assess the functional capacity and the impact of each block on the ability to walk by measuring the distance (the 2 minute walk test) in post op day one in the two groups.	post op day one

Secondary

Measure	Time frame
the morphine consumption in the two groups.	post op day one

Countries

Canada

Contacts

Primary ContactJF Asengo, MD

jfasenjog@yahoo.com(514) 934-1934

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026